Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-05-31

Clinical Trial Update: Oxytocin, Carbetocin and Misopristol for Treatment of Postpartum Hemorrhage: A Multicentric Randomized Trial [NA]

View source ↗

Summary

Clinical trial evaluating oxytocin, carbetocin, and misoprostol for treating postpartum hemorrhage; the current status is unspecified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbetocin (carbetocin)
  • MISOPROSTOL (Misoprostol)
  • Oxytocin (Oxytocin)

Snippet

Sponsor: Sohag University | Conditions: Postpartum Hemorrhage | NA | Status: UNKNOWN